<SEC-DOCUMENT>0000950103-25-001841.txt : 20250211
<SEC-HEADER>0000950103-25-001841.hdr.sgml : 20250211
<ACCEPTANCE-DATETIME>20250211085412
ACCESSION NUMBER: 0000950103-25-001841
CONFORMED SUBMISSION TYPE: 424B2
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20250211
DATE AS OF CHANGE: 20250211
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CITIGROUP INC
CENTRAL INDEX KEY: 0000831001
STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 521568099
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 424B2
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-270327
FILM NUMBER: 25607831
BUSINESS ADDRESS:
STREET 1: 388 GREENWICH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: 2125591000
MAIL ADDRESS:
STREET 1: 388 GREENWICH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: TRAVELERS GROUP INC
DATE OF NAME CHANGE: 19950519
FORMER COMPANY:
FORMER CONFORMED NAME: TRAVELERS INC
DATE OF NAME CHANGE: 19940103
FORMER COMPANY:
FORMER CONFORMED NAME: PRIMERICA CORP /NEW/
DATE OF NAME CHANGE: 19920703
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Citigroup Global Markets Holdings Inc.
CENTRAL INDEX KEY: 0000200245
STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 112418067
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 424B2
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-270327-01
FILM NUMBER: 25607832
BUSINESS ADDRESS:
STREET 1: 388 GREENWICH ST
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: 212-816-6000
MAIL ADDRESS:
STREET 1: 388 GREENWICH ST
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: CITIGROUP GLOBAL MARKETS HOLDINGS INC
DATE OF NAME CHANGE: 20030404
FORMER COMPANY:
FORMER CONFORMED NAME: SALOMON SMITH BARNEY HOLDINGS INC
DATE OF NAME CHANGE: 19971128
FORMER COMPANY:
FORMER CONFORMED NAME: SALOMON INC
DATE OF NAME CHANGE: 19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp224786_424b2-25nir008777d.htm
<DESCRIPTION>PRELIMINARY PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">
<P STYLE="margin: 0pt"> </P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 100%">
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red">The information in this preliminary
pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the
Securities and Exchange Commission. This preliminary pricing supplement and the accompanying prospectus supplement and prospectus are
not an offer to sell these securities, nor are they soliciting an offer to buy these securities, in any state where the offer or sale
is not permitted. </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red">SUBJECT TO COMPLETION, DATED FEBRUARY
11, 2025 </P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 55%; font-size: 10pt; color: #888888"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
<TD STYLE="width: 45%">
<P STYLE="color: #888888; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><B>February
, 2025</B></P>
<P STYLE="color: #888888; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><B>Medium-Term Senior Notes,
Series N</B></P>
<P STYLE="color: #888888; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><B>Pricing Supplement No. 2025-USNCH25780</B></P>
<P STYLE="color: #888888; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(2)</B></P>
<P STYLE="color: #888888; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><B>Registration Statement Nos.
333-270327 and 333-270327-01</B></P></TD></TR>
</TABLE>
<P STYLE="color: #F19300; font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Principal-at-Risk Securities Linked to the Synthetic
5Y5Y EUR CMS Rate Due May 14, 2025</P>
<P STYLE="color: #F19300; font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">▪</FONT></TD><TD>The securities offered by this pricing supplement are unsecured
debt securities issued by Citigroup Global Markets Holdings Inc. and guaranteed by Citigroup Inc. Unlike conventional debt
securities, the securities do not pay interest and do not repay a fixed amount of principal at maturity. Instead, the securities
offer a payment at maturity that may be greater than, equal to or less than the issue price, depending on the synthetic 5Y5Y EUR CMS
rate on the valuation date. The synthetic 5Y5Y EUR CMS rate on any date is intended to represent the EUR ICE swap rate for
the 5-year period starting 5 years from the current date. We refer to this rate as “synthetic” because it is not
a directly market-observable rate, and for purposes of the securities is calculated “synthetically” using a formula based
on the 10-year EUR ICE swap rate and the 5-year EUR ICE swap rate on the current date, as specified in more detail below.</TD>
</TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">▪</FONT></TD><TD>Investors will receive the maximum payment at maturity specified
below only if the synthetic 5Y5Y EUR CMS rate on the valuation date is greater than or equal to the strike specified below. If
the synthetic 5Y5Y EUR CMS rate on the valuation date is less than the strike, investors will receive less than the maximum payment at
maturity and may receive less, and possibly significantly less, than the stated principal amount. In that instance, the greater
the difference between the synthetic 5Y5Y EUR CMS rate on the valuation date and the strike, the lower your payment at maturity, subject
to the minimum payment at maturity. If the synthetic 5Y5Y EUR CMS rate on the valuation date is less than the strike by an
amount that is equal to or greater than the OTM strike width specified below, investors will receive only the minimum payment at maturity
specified below, representing a significant loss on an investment in the securities.</TD>
</TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">▪</FONT></TD><TD><B>The securities are highly risky investments. A
relatively small decrease in the synthetic 5Y5Y EUR CMS rate as of the valuation date compared to the strike will result in the loss
of a significant portion of your investment.</B></TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">▪</FONT></TD><TD>Investors in the securities must be willing to accept (i) an
investment that may have limited or no liquidity and (ii) the risk of not receiving any amount due under the securities if we and Citigroup
Inc. default on our obligations. <B>All payments on the securities are subject to the credit risk of Citigroup Global Markets Holdings
Inc. and Citigroup Inc.</B></TD>
</TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: #F19300">
<TD STYLE="width: 24%"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS</B></FONT></TD>
<TD STYLE="width: 76%"> </TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Issuer:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Guarantee:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Issue price: </B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">100.00% of the stated principal amount (€1,000 per €1,000 stated principal amount security)</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Stated principal amount: </B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">€1,000 per security</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Synthetic 5Y5Y EUR CMS rate:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">On any date, (2 × EUR CMS10) <I>minus</I> EUR CMS5, each as determined on that date.</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>EUR CMS10 and EUR CMS5:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">On any date, “EUR CMS10” is the 10-year EUR ICE swap rate and “EUR CMS5” is the 5-year EUR ICE swap rate, in each case, on that date, determined as set forth under “Additional Terms of the Securities” below. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Strike date:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">February 10, 2025</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Pricing date:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">February 11, 2025</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Issue date:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">February 19, 2025</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Valuation date:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">May 12, 2025 or, if such day is not a TARGET business day, the next succeeding TARGET business day</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Maturity date: </B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">May 14, 2025. If the maturity date is not a business day, the payment due on that date will be paid on the next succeeding business day, and no interest will accrue as a result of the delay in payment.</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Payment at maturity:</B></FONT></TD>
<TD>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For each €1,000 stated principal amount security you hold at maturity,
you will receive an amount determined as follows:</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">·</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"> </FONT>If the synthetic 5Y5Y EUR CMS rate on the valuation date is greater than or equal to the strike, the maximum payment at maturity</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">·</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">
</FONT>If the synthetic 5Y5Y EUR CMS rate on the valuation date is less than the strike, an amount calculated as follows:</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.75in">the maximum payment at maturity <I>minus</I> [€1,000
× the product (expressed as a percentage) of (a) (1 / OTM strike width) × (b) (the strike <I>minus</I> the synthetic 5Y5Y
EUR CMS rate on the valuation date)], subject to the minimum payment at maturity </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the synthetic 5Y5Y EUR CMS rate on the valuation date is less
than the strike, then the greater that difference, the lower your payment at maturity, subject to the minimum payment at maturity. You
could lose a significant portion of your investment in the securities.</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Strike:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">2.412%, determined on the strike date in the sole discretion of the calculation agent</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>OTM strike width:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">0.50%</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Maximum payment at maturity:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Minimum payment at maturity:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">€208.75</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Listing:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>CUSIP / ISIN:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">5C3I8G9M7 / XS2982227790</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD><FONT STYLE="font-size: 10pt; color: #F19300"><B>Underwriter:</B></FONT></TD>
<TD><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (“CGMI”), an affiliate of the issuer, acting as principal</FONT></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="background-color: #FBF0E8">
<TD STYLE="vertical-align: top; width: 24%"><FONT STYLE="font-size: 10pt; color: #F19300"><B>Underwriting fee and issue price:</B></FONT></TD>
<TD STYLE="width: 28%; text-align: center; font-size: 10pt; color: #F19300"><B>Issue price<SUP>(1)</SUP></B></TD>
<TD STYLE="width: 24%; text-align: center; font-size: 10pt; color: #F19300"><B>Underwriting fee<SUP>(2)</SUP></B></TD>
<TD STYLE="width: 24%; text-align: center; font-size: 10pt; color: #F19300"><B>Proceeds to issuer</B></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt; color: rgb(241,147,0)"><B>Per security:</B></FONT></TD>
<TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">€1,000.00</FONT></TD>
<TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">€0.00</FONT></TD>
<TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">€1,000.00</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt; color: #F19300"><B>Total:</B></FONT></TD>
<TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">€</FONT></TD>
<TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">€</FONT></TD>
<TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">€</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(1) Citigroup Global Markets Holdings Inc. currently expects that the
estimated value of the securities on the pricing date will be between €900.00 and €1,000.00 per security, which may be less
than the issue price. The estimated value of the securities is based on CGMI’s proprietary pricing models and our internal funding
rate. It is not an indication of actual profit to CGMI or other of our affiliates, nor is it an indication of the price, if any, at which
CGMI or any other person may be willing to buy the securities from you at any time after issuance. See “Valuation of the Securities”
in this pricing supplement.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">(2) For more information on the distribution of the securities, see
“Supplemental Plan of Distribution” in this pricing supplement. CGMI and its affiliates may profit from expected
hedging activity related to this offering, even if the value of the securities declines. See “Use of Proceeds and Hedging”
in the accompanying prospectus.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See “Risk Factors Relating to the Securities” beginning on page PS-4.</B></P>
<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
(the “SEC”) nor any state securities commission has approved or disapproved of the securities or determined that this pricing
supplement and the accompanying prospectus supplement and prospectus is truthful or complete. Any representation to the contrary is a
criminal offense.</B> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>You should read this pricing supplement together
with the accompanying prospectus supplement and prospectus, each of which can be accessed via the hyperlink below:</I></B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
<P STYLE="color: #F29400; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(241,147,0); text-decoration: underline">Prospectus Supplement and Prospectus each dated March 7, 2023</A></P>
<P STYLE="color: #F29400; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"> </P>
<!-- Field: Page; Sequence: 1 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="border-bottom: #F19300 1pt solid; width: 100%; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"><FONT STYLE="font-weight: normal">Hypothetical Examples</FONT></P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The table and examples below illustrate various hypothetical payments
at maturity based on various hypothetical synthetic 5Y5Y EUR CMS rates on the valuation date. The outcomes below are not exhaustive. Your
actual payment at maturity will depend on the actual synthetic 5Y5Y EUR CMS rate on the valuation date. </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The table and examples are for purposes of illustration only and have
been rounded for ease of analysis. </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD STYLE="width: 33%; border: Black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #F19300"><B>Hypothetical Synthetic 5Y5Y EUR</B></FONT></P>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #F19300"><B>CMS Rate on the Valuation Date</B></FONT></P></TD>
<TD STYLE="width: 31%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #F19300"><B>Hypothetical Payment at</B></FONT></P>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #F19300"><B>Maturity per Security</B></FONT></P></TD>
<TD STYLE="width: 36%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #F19300"><B>Hypothetical Total Return on</B></FONT></P>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt; color: #F19300"><B>Securities<SUP>(1)</SUP></B></FONT></P></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">3.500000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">3.400000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">3.300000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">3.200000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">3.100000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">3.000000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.900000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.800000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.700000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.600000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.500000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR STYLE="background-color: #BFBFBF">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.412000%</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,208.75</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.875%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.400000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,184.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">18.475%</FONT></TD></TR>
<TR STYLE="background-color: #BFBFBF">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.307625%</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€1,000.00</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">0.000%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.300000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"> €984.75 </FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-1.525%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.200000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"> €784.75 </FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-21.525%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.100000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"> €584.75 </FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-41.525%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">2.000000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"> €384.75 </FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-61.525%</FONT></TD></TR>
<TR STYLE="background-color: #BFBFBF">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1.912000%</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€208.75</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-79.125%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1.900000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-79.125%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1.800000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-79.125%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1.700000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-79.125%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1.600000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-79.125%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1.500000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-79.125%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1.400000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-79.125%</FONT></TD></TR>
<TR>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">1.300000%</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">€208.75</FONT></TD>
<TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-79.125%</FONT></TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><SUP>(1)</SUP></TD><TD>The “hypothetical total return on the securities” is equal to (i) (a) the hypothetical payment at maturity per security
<I>minus </I>(b) the issue price of €1,000.00 per security, <I>divided by</I> (ii) the issue price of €1,000.00 per security.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1: </B>The synthetic 5Y5Y EUR CMS rate on the valuation date
is 2.600%, which is greater than the strike.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this example, since the synthetic 5Y5Y EUR CMS rate on the valuation
date is greater than or equal to the strike, you would receive the maximum payment at maturity of €1,208.75 per security and your
total return at maturity would be equal to 20.875%.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2: </B>The synthetic 5Y5Y EUR CMS rate on the valuation date
is 2.400%, which is less than the strike.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = the maximum payment at maturity <I>minus</I>
[€1,000 × the product (expressed as a percentage) of (a) (1 / OTM strike width) × (b) (the strike <I>minus</I> the synthetic
5Y5Y EUR CMS rate on the valuation date)], subject to the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> [€1,000 × the product (expressed
as a percentage) of (a) (1 / 0.50%) × (b) (2.412% - 2.400%)], subject to the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> [€1,000 × the product (expressed
as a percentage) of (a) 200 × (b) 0.012%], subject to the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> [€1,000 × 2.40%], subject to
the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> €24.00, subject to the minimum payment
at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,184.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this example, the payment at maturity per security would be €1,184.75
and your total return at maturity would be equal to 18.475%.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3: </B>The synthetic 5Y5Y EUR CMS rate on the valuation date
is 2.200%, which is less than the strike.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = the maximum payment at maturity <I>minus</I>
[€1,000 × the product (expressed as a percentage) of (a) (1 / OTM strike width) × (b) (the strike <I>minus</I> the synthetic
5Y5Y EUR CMS rate on the valuation date)], subject to the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> [€1,000 × the product (expressed
as a percentage) of (a) (1 / 0.50%) × (b) (2.412% - 2.200%)], subject to the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> [€1,000 × the product (expressed
as a percentage) of (a) 200 × (b) 0.212%], subject to the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> [€1,000 × 42.40%], subject
to the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> €424.00, subject to the minimum payment
at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €784.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this example, the payment at maturity per security would be €784.75
and your total return at maturity would be equal to -21.525%, representing a significant loss on your investment.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 4</B>: The synthetic 5Y5Y EUR CMS rate on the valuation date
is 1.600%, which is less than the strike.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity per security = the maximum payment at maturity <I>minus</I>
[€1,000 × the product (expressed as a percentage) of (a) (1 / OTM strike width) × (b) (the strike <I>minus</I> the synthetic
5Y5Y EUR CMS rate on the valuation date)], subject to the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> [€1,000 × the product (expressed
as a percentage) of (a) (1 / 0.50%) × (b) (2.412% - 1.600%)], subject to the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> [€1,000 × the product (expressed
as a percentage) of (a) 200 × (b) 0.812%], subject to the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> [€1,000 × 162.40%], subject
to the minimum payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €1,208.75 <I>minus</I> €1,624.00, subject to the minimum
payment at maturity of €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= €208.75</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this example, the payment at maturity per security would be the minimum
payment at maturity of €208.75 and your total return at maturity would be equal to -79.125%, representing a significant loss on your
investment.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<!-- Field: Page; Sequence: 3; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"><FONT STYLE="font-weight: normal">Risk Factors Relating
to the Securities</FONT></P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities. The securities are subject to all of the risks associated with an investment in our conventional
debt securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the
securities, and are also subject to risks associated with the synthetic 5Y5Y EUR CMS rate. Accordingly, the securities are
suitable only for investors who are capable of understanding the complexities and risks of the securities. You should consult
your own financial, tax and legal advisers as to the risks of an investment in the securities and the suitability of the securities in
light of your particular circumstances.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a description of certain key risk factors for investors
in the securities. You should also carefully read the risk factors included in the accompanying prospectus supplement and in
the documents incorporated by reference in the accompanying prospectus, including Citigroup Inc.’s most recent Annual Report on
Form 10-K and any subsequent Quarterly Reports on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The securities are highly risky, and you may lose a significant portion of your investment. </B>Unlike conventional
debt securities, the securities do not repay a fixed amount of principal at maturity. Instead, the securities offer a payment
at maturity that may be greater than, equal to or less than the issue price, depending on the synthetic 5Y5Y EUR CMS rate on the valuation
date. If the synthetic 5Y5Y EUR CMS rate on the valuation date is less than the strike, then the greater that difference, the
lower your payment at maturity, subject to the minimum payment at maturity. If the synthetic 5Y5Y EUR CMS rate on the valuation
date is less than the strike by an amount equal to or greater than the OTM strike width, you will receive only the minimum payment at
maturity and will lose a significant portion of your investment in the securities.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The strike, set on the strike date, may be higher than the synthetic 5Y5Y EUR CMS rate on the pricing date.</B> If the synthetic
5Y5Y EUR CMS rate on the pricing date is less than the strike set on the strike date, the terms of the securities may be less favorable
to you than the terms of an alternative investment that may be available to you that offers a similar payout as the securities but with
the strike set on the pricing date.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>Relatively small differences in the synthetic 5Y5Y EUR CMS rate on the valuation date will significantly affect the payment at
maturity.</B> For example, a hypothetical synthetic 5Y5Y EUR CMS rate on the valuation date of 2.100% as compared to the strike
of 2.412% would represent a 41.525% loss on the securities (as a percentage of the issue price), whereas a hypothetical synthetic 5Y5Y
EUR CMS rate on the valuation date of 2.300% would represent a 1.525% loss on the securities. In this illustration, a 0.200%
difference between these two hypothetical synthetic 5Y5Y EUR CMS rates on the valuation date results in a 40.000% difference in your return
on the securities. The fact that relatively small differences in the synthetic 5Y5Y EUR CMS rate on the valuation date will
result in large differences in the payment at maturity on the securities magnifies the riskiness of the securities.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The securities do not pay interest.</B> The securities are not appropriate for investors who require regular payments
of interest.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The securities will be adversely affected by volatility in the synthetic 5Y5Y EUR CMS rate.</B> The securities will
pay the maximum payment at maturity if the synthetic 5Y5Y EUR CMS rate on the valuation date is greater than or equal to the strike. If
the synthetic 5Y5Y EUR CMS rate on the valuation date is less than the strike, then the greater that difference, the lower your payment
at maturity. The more volatile the synthetic 5Y5Y EUR CMS rate, the greater the likelihood that the synthetic 5Y5Y EUR CMS
rate on the valuation date will differ significantly from the strike. As a result, the securities will be adversely affected
by volatility in the synthetic 5Y5Y EUR CMS rate.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>Your potential return on the securities is limited. </B>Your potential total return on the securities at maturity is
limited to the difference between the maximum payment at maturity and the issue price per security, regardless of the synthetic 5Y5Y EUR
CMS rate during the term of the securities. </TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The strike is determined at the discretion of Citibank N.A., as the calculation agent. </B>The strike is determined
by the calculation agent on the strike date in its sole discretion. The strike may reflect a higher or lower value than might
be available to you on other instruments on the pricing date or strike date, and the discretion exercised by the calculation agent in
determining the strike could have an impact (positive or negative) on the value of, and your return on, the securities. The calculation
agent is under no obligation to consider your interests as a holder of the securities in taking any actions that might affect the value
of the securities, including the determination of the strike.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The manner in which the synthetic 5Y5Y EUR CMS rate is calculated for purposes of the securities may fail to accurately measure
the EUR ICE swap rate for the 5-year period starting 5 years in the future. </B>The EUR ICE swap rate for the 5-year period
starting 5 years in the future is not directly market-observable and may only be calculated on a synthetic basis. For purposes
of the securities, that rate is calculated in accordance with the formula for the synthetic 5Y5Y EUR CMS rate set forth in this pricing
supplement. This manner of calculating the synthetic 5Y5Y EUR CMS rate may differ from other methods of calculating this rate
that could have been used, and may result in a lower return on the securities than other methods.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>Your payment at maturity depends on the synthetic 5Y5Y EUR CMS rate on a single day.</B> Because your payment at maturity
depends on the synthetic 5Y5Y EUR CMS rate solely on the valuation date, you are subject to the risk that the synthetic 5Y5Y</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<!-- Field: Page; Sequence: 4; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">EUR CMS rate on that day may differ from
the strike by a greater amount on that day than on one or more other dates during the term of the securities. If you had invested
in another instrument linked to the synthetic 5Y5Y EUR CMS rate that you could sell for full value at a time selected by you, or if the
payment at maturity were based on an average of synthetic 5Y5Y EUR CMS rates on several dates, you might have achieved better returns.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc. </B>If we default on
our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you
under the securities. In addition, changes in our actual or perceived creditworthiness are likely to affect the value of the securities
prior to maturity.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.</B> The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI’s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor
must be prepared to hold the securities until maturity.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI’s proprietary pricing models and our internal funding
rate, may be less than the issue price.</B> The difference is attributable to certain costs associated with selling, structuring and hedging
the securities that are included in the issue price. These costs include (i) any selling concessions paid in connection with the offering
of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of the securities and
(iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection with hedging
our obligations under the securities. These costs adversely affect the economic terms of the securities because, if they were lower, the
economic terms of the securities would be more favorable to you. The economic terms of the securities are also likely to be adversely
affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities. See “The estimated
value of the securities would be lower if it were calculated based on our secondary market rate” below.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.</B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of the synthetic 5Y5Y EUR CMS rate and the level of
interest rates generally. CGMI’s views on these inputs may differ from your or others’ views, and as an underwriter in this
offering, CGMI’s interests may conflict with yours. Both the models and the inputs to the models may prove to be wrong and therefore
not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities set forth on the cover page
of this pricing supplement may differ from the value that we or our affiliates may determine for the securities for other purposes, including
for accounting purposes. You should not invest in the securities because of the estimated value of the securities. Instead, you should
be willing to hold the securities to maturity irrespective of the initial estimated value.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The estimated value of the securities would be lower if it were calculated based on our secondary market rate.</B> The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which
we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any purchases of the securities
from you in the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate,
rather than our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs
associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity
needs and preferences. Our internal funding rate is not an interest rate that we will pay to investors in the securities.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Because there is not an active market for
traded instruments referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of
traded instruments referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the
securities, but subject to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined
measure of our creditworthiness, but rather reflects the market’s perception of our parent company’s creditworthiness as adjusted
for discretionary factors such as CGMI’s preferences with respect to purchasing the securities prior to maturity.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of
the securities based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included
in this pricing supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our
secondary market rate, which will likely result in a lower value for the securities than if our internal funding rate were used. In addition,
any secondary market price for the securities will be reduced by a bid-ask spread, which may vary depending on</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<!-- Field: Page; Sequence: 5; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">the aggregate stated principal amount of
the securities to be purchased in the secondary market transaction, and the expected cost of unwinding related hedging transactions. As
a result, it is likely that any secondary market price for the securities will be less than the issue price.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors.</B> The value of your
securities prior to maturity will fluctuate based on the value and volatility of the synthetic 5Y5Y EUR CMS rate and a number of other
factors, including those described below. Some of these factors are interrelated in complex ways. As a result, the effect of any one factor
may be offset or magnified by the effect of one or more other factors. The paragraphs below describe what we expect to be the impact on
the value of the securities of a change in a specific factor, assuming all other conditions remain constant. You should understand that
the value of your securities at any time prior to maturity may be significantly less than the issue price.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">▪</TD><TD><I>Synthetic 5Y5Y EUR CMS rate</I>. We expect that the value of the securities at any time prior to maturity will depend substantially
on the synthetic 5Y5Y EUR CMS rate at that time.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">▪</TD><TD><I>Volatility of the synthetic 5Y5Y EUR CMS rate.</I> Volatility refers to the magnitude and frequency of changes in the synthetic
5Y5Y EUR CMS rate over any given period. Any increase in the expected volatility of the synthetic 5Y5Y EUR CMS rate may adversely affect
the value of the securities.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">▪</TD><TD><I>Interest rates.</I> We expect that the value of the securities will be affected by changes in euro interest rates.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">▪</TD><TD><I>Time remaining to maturity.</I> At any given time, a portion of the value of the securities will be attributable to time value,
which is based on the amount of time then remaining to maturity. If you sell the securities at any time prior to maturity, you will be
giving up any increase in the time value of the securities that may result as the time remaining to maturity shortens.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">▪</TD><TD><I>Creditworthiness of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</I> The securities are subject to the credit risk
of Citigroup Global Markets Holdings Inc. and Citigroup Inc. Therefore, actual or anticipated adverse changes in the creditworthiness
of Citigroup Global Markets Holdings Inc. and Citigroup Inc. may adversely affect the value of the securities.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">It is important for you to understand that the impact of
one of the factors discussed above may offset, or magnify, some or all of any change in the value of the securities attributable to one
or more of the other factors.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.</B> The amount of this temporary upward
adjustment will steadily decline to zero over the temporary adjustment period. See “Valuation of the Securities” in this pricing
supplement.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>EUR ICE swap rates are affected by a number of factors and may be highly volatile. </B>EUR ICE swap rates are influenced by many
factors, including:</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>the monetary policies of the European Central Bank;</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>current market expectations about future interest rates;</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>current market expectations about inflation;</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>the volatility of the foreign exchange markets;</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>the availability of relevant hedging instruments;</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>the perceived general creditworthiness of the banks that participate in the interest rate swap market and the Eurozone interbank loan
market; and</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>general credit and economic conditions in global markets, and particularly in the United States and the Eurozone.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">As a result of these factors, EUR ICE swap
rates may be highly volatile. Because EUR ICE swap rates are market rates and are influenced by many factors, it is impossible to predict
the future value of any EUR ICE swap rate.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The offering of the securities does not constitute a recommendation to invest in an instrument linked to the synthetic 5Y5Y EUR
CMS rate by CGMI or its affiliates</B>. You should not take the offering of the securities as an expression of our views or the views
of our affiliates regarding how the synthetic 5Y5Y EUR CMS rate will perform in the future or as a recommendation to invest in an instrument
linked to the synthetic 5Y5Y EUR CMS rate, including through an investment in the securities. As we are part of a global financial institution,
our affiliates may, and often do, have positions that conflict with an investment in the securities. You should undertake an independent
determination of whether an investment in the securities is suitable for you in light of your specific investment objectives, risk tolerance
and financial resources.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<!-- Field: Page; Sequence: 6; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>Our affiliates may have published research, expressed opinions or provided recommendations that are inconsistent with investing
in the securities and may do so in the future, and any such research, opinions or recommendations could adversely affect the synthetic
5Y5Y EUR CMS rate. </B>CGMI and other of our affiliates may publish research from time to time relating to the synthetic 5Y5Y EUR CMS
rate. Any research, opinions or recommendations provided by CGMI and other of our affiliates may influence the synthetic 5Y5Y
EUR CMS rate, and they may be inconsistent with purchasing or holding the securities. CGMI and other of our affiliates may have published
or may publish research or other opinions that call into question the investment view implicit in an investment in the securities. Investors
should make their own independent investigation of the synthetic 5Y5Y EUR CMS rate and the merits of investing in the securities.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The synthetic 5Y5Y EUR CMS rate may be affected by our or our affiliates’ hedging and other trading activities. </B>In anticipation
of the sale of the securities, we expect to hedge our obligations under the securities through CGMI or other of our affiliates, who may
take positions in the interest rate swaps from which the synthetic 5Y5Y EUR CMS rate is ultimately derived and may adjust such positions
during the term of the securities. We or our counterparties may also adjust this hedge during the term of the securities and
close out or unwind this hedge on the valuation date, which may involve, among other things, our counterparties purchasing or selling
such interest rate swaps. This hedging activity during the term of the securities, including on the valuation date, could affect
the synthetic 5Y5Y EUR CMS rate, including on the valuation date, in a way that adversely affects your payment at maturity. This hedging
activity may present a conflict of interest between your interests as a holder of the securities and the interests we and/or our counterparties,
which may be our affiliates, have in executing, maintaining and adjusting hedging transactions. These hedging activities could
also affect the price, if any, at which CGMI may be willing to purchase your securities in a secondary market transaction.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">CGMI and other of our affiliates may also
trade the interest rate swaps from which the synthetic 5Y5Y EUR CMS rate is ultimately derived on a regular basis (taking long or short
positions or both), for their accounts, for other accounts under their management or to facilitate transactions, including block transactions,
on behalf of customers. As with our or our affiliates’ hedging activity, this trading activity could affect the synthetic 5Y5Y EUR
CMS rate, including on the valuation date, in a way that adversely affects the performance of the securities.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">It is possible that these hedging or trading activities could
result in substantial returns for our affiliates while the value of the securities declines.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>A lack of input data may impact IBA’s ability to calculate and publish the EUR ICE swap rates. </B>The input data for the
EUR ICE swap rates is based on swaps referencing EURIBOR as the floating leg. The EUR ICE swap rates are dependent on receiving
sufficient eligible input data from the trading venue sources identified by IBA in accordance with the “Waterfall” methodology
for each EUR ICE swap rate. The ability of the applicable trading venues to provide sufficient eligible input data in accordance
with the Waterfall methodology depends on, among other things, there being a liquid market in swap contracts referencing EURIBOR on such
trading venues, which in turn depends, among other things, on there being a liquid market in loans, floating rate notes and other financial
contracts referencing EURIBOR. If the market for EURIBOR-based swap contracts is not sufficiently liquid, or if the liquidity
in such market proves to be volatile, this could result in the inability of IBA to calculate a EUR ICE swap rate, which could adversely
affect the return on and value of the securities and the price at which you are able to sell the securities in the secondary market, if
any. In addition, if EURIBOR does not maintain market acceptance for use as a reference rate for euro denominated financial contracts,
uncertainty about EURIBOR may adversely affect the return on and the value of the securities.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The way EUR ICE swap rates are calculated may change in the future, which could adversely affect the value of the securities.</B>
The method by which the EUR ICE swap rates are calculated may change in the future, as a result of governmental actions, actions by the
publisher of the EUR ICE swap rates or otherwise. We cannot predict whether the method by which the EUR ICE swap rates are calculated
will change or what the impact of any such change might be. Any such change could affect the EUR ICE swap rates in a way that has a significant
adverse effect on the securities.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The EUR ICE swap rates may be determined by the calculation agent in good faith using its reasonable judgment. </B>If, on the valuation
date, a EUR ICE swap rate is not published (subject to a discontinuance as described below), then the applicable EUR ICE swap rate on
that day will be determined by the calculation agent in good faith and using its reasonable judgment. A EUR ICE swap rate determined in
this manner and used in the determination of the payment at maturity on the securities may be different from the EUR ICE swap rate that
would have been published by the administrator of the EUR ICE swap rate.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #F19300">■</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B> If
certain events occur, Citibank, N.A., as calculation agent, will be required to make certain discretionary judgments that could significantly
affect your payment at maturity. Such judgments could include, among other things, determining a EUR ICE swap rate under the circumstances
described herein, selecting a successor rate if a EUR ICE swap rate is discontinued and, if no successor rate is selected, calculating
the applicable EUR ICE swap rate in good faith and using its reasonable judgment. Any of these determinations made by Citibank, N.A. in
its capacity as calculation agent may adversely affect any payment owed to you under the securities.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: #F19300">■</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the securities are unclear. </B>There is no direct legal authority regarding
the proper U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<!-- Field: Page; Sequence: 7; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">(the “IRS”). Consequently, significant aspects
of the tax treatment of the securities are uncertain, and the IRS or a court might not agree with the treatment of the securities as prepaid
financial contracts that are “open transactions.” If the IRS were successful in asserting an alternative treatment of the
securities, the tax consequences of the ownership and disposition of the securities might be materially and adversely affected. Additionally,
even under our intended characterization of the securities, there is significant uncertainty about whether the character of any gain or
loss you recognize upon a taxable disposition of the securities should be treated as short-term capital gain or loss, ordinary foreign
currency gain or loss, or, in the case of gain or loss recognized at maturity, ordinary income or loss (other than foreign currency gain
or loss). Among other things, an ordinary loss (other than a foreign currency loss, as discussed below) recognized by an individual might
be treated as a non-deductible “miscellaneous itemized deduction.” Moreover, future legislation, Treasury regulations or IRS
guidance could adversely affect the U.S. federal tax treatment of the securities, possibly retroactively.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">If you are a non-U.S. investor, you should review the discussion
of withholding tax issues in “United States Federal Tax Considerations—Non-U.S. Holders” below.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">You should read carefully the discussion under “United
States Federal Tax Considerations” in this pricing supplement. You should also consult your tax adviser regarding the U.S. federal
tax consequences of an investment in the securities, as well as tax consequences arising under the laws of any state, local or non-U.S.
taxing jurisdiction.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"> </P>
<!-- Field: Page; Sequence: 8; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"><FONT STYLE="font-weight: normal">Additional Terms of
the Securities</FONT></P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>General</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The provisions in this section supersede the related provisions in the
accompanying prospectus supplement and prospectus to the extent the provisions in this section are inconsistent with those provisions.
The accompanying prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing supplement.
It is important that you read the accompanying prospectus supplement and prospectus together with this pricing supplement before deciding
whether to invest in the securities.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities are unsecured debt securities issued by Citigroup Global
Markets Holdings Inc. under the senior debt indenture described in the accompanying prospectus supplement and prospectus, the payments
on which are fully and unconditionally guaranteed by Citigroup Inc. The securities will constitute part of the senior debt of Citigroup
Global Markets Holdings Inc. and will rank equally with all other unsecured and unsubordinated debt of Citigroup Global Markets Holdings
Inc. The guarantee of payments due on the securities will constitute part of the senior indebtedness of Citigroup Inc. and will rank on
an equal basis with all other unsecured debt of Citigroup Inc. other than subordinated debt.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities will be cleared through Euroclear Bank S.A./N.V. (“Euroclear”)
and Clearstream Banking S.A. (“Clearstream”), and not through DTC. The securities will be issued under the Classic Safekeeping
Structure registered in the name of Citivic Nominees Limited, as nominee for Citibank, N.A., London Branch, as common depositary for interests
held through Euroclear and Clearstream. Beneficial interests in the securities will be shown on, and transfers thereof will be effected
only through, records maintained by Euroclear, Clearstream and their participants. Except as described under “Description of Debt
Securities—Book-Entry Procedures and Settlement—Definitive Notes and Paying Agents” in the accompanying prospectus,
individual registered certificates will not be issued in exchange for beneficial interests in the global notes evidencing the securities.
The securities are not Eurosystem eligible.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A fiscal agency agreement has been entered into in relation to the securities
between the issuer and Citibank, N.A., London Branch, as fiscal and paying agent. The holders of the securities are bound by, and are
deemed to have notice of, the provisions of the fiscal agency agreement. Copies of the fiscal agency agreement are available for inspection
during usual business hours at the principal office of Citibank, N.A., London Branch, located at Citigroup Centre, Canada Square, Canary
Wharf, London, England.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Subject to applicable law and the terms of the indenture, the issuer
and the fiscal and paying agent will treat the persons in whose names the securities are registered, initially Citivic Nominees Limited,
as owners of such notes for the purpose of receiving any payments on the securities and for all other purposes whatsoever. Therefore,
none of the issuer nor any agent has any direct responsibility or liability for any payment on the securities to owners of beneficial
interests in the securities. Any payments made by the issuer to the registered holders of the securities shall discharge the liability
of the issuer under the securities to the extent of the sums so paid.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A “business day” with respect to the securities means a
day on which commercial banks settle payments and are open for general business in each of New York City and London.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The provisions set forth under “Supplemental Provisions Relating
to Non-U.S. Dollar Notes—Public Offering Price” in the accompanying prospectus supplement do not apply to the securities.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Euroclear and Clearstream</I></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Euroclear and Clearstream each holds securities for its customers and
facilitates the clearance and settlement of securities transactions by electronic book-entry transfer between their respective accountholders.
Euroclear and Clearstream provide various services including safekeeping, administration, clearance and settlement of internationally
traded securities and securities lending and borrowing. Euroclear and Clearstream also deal with domestic securities markets in several
countries through established depository and custodial relationships. Euroclear and Clearstream have established an electronic bridge
between their two systems across which their respective participants may settle trades with each other.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Euroclear and Clearstream customers are world-wide financial institutions,
including underwriters, securities brokers and dealers, banks, trust companies and clearing corporations. Indirect access to Euroclear
and Clearstream is available to other institutions that clear through or maintain a custodial relationship with an accountholder of either
system.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Determination of a EUR ICE Swap Rate</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The synthetic 5Y5Y EUR CMS rate on any date is calculated based on EUR
CMS10 and EUR CMS5 on that date. Each of EUR CMS10 and EUR CMS5 is a “EUR ICE swap rate”.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A EUR ICE swap rate of a given maturity on any date of determination
is the swap rate for a fixed-for-floating EURIBOR-linked interest rate swap transaction with that maturity in euro appearing on Bloomberg
page “EUAMDB” (or any successor page as determined by the calculation agent) as of 11:00 a.m. (Frankfurt time) on that date
of determination. If the applicable EUR ICE swap rate is not published on Bloomberg page “EUAMDB” (or any successor
page as determined by the calculation agent) on any TARGET business day on</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<!-- Field: Page; Sequence: 9; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">which such rate is required (subject to “—Discontinuance
of a EUR ICE Swap Rate” below), then the applicable EUR ICE swap rate for that date will be determined by the calculation agent
in good faith and using its reasonable judgment.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In a fixed-for-floating EURIBOR-linked interest rate swap transaction,
one party pays a fixed rate (the “swap rate”) and the other pays a floating rate based on the Euro Interbank Offered Rate
(“EURIBOR”). EURIBOR is a measure of the rate at which banks lend euro to each other in the euro interbank market
and is a common rate of interest used in the swaps industry.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">IBA is the current administrator of the EUR ICE swap rate. According
to publicly available information (which we have not independently verified), IBA currently determines the EUR ICE swap rate based on
a “waterfall” methodology using eligible input data in respect of EURIBOR-linked interest rate swaps. The first
level of the waterfall (“Level 1”) uses eligible, executable prices and volumes provided by regulated, electronic, trading
venues. If these trading venues do not provide sufficient eligible input data to calculate a rate in accordance with Level 1 of the methodology,
then the second level of the waterfall (“Level 2”) uses eligible dealer to client prices and volumes displayed electronically
by trading venues. If there is insufficient eligible input data to calculate a rate in accordance with Level 2 of the waterfall, then
the third level of the waterfall (“Level 3”) uses movement interpolation, where possible for applicable tenors, to calculate
a rate. Where it is not possible to calculate a EUR ICE swap rate at Level 1, Level 2 or Level 3 of the waterfall on a given
date, then the EUR ICE swap rate will not be published for that date.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Discontinuance of a EUR ICE Swap Rate</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the calculation and publication of a EUR ICE swap rate is permanently
canceled, then the calculation agent may identify an alternative rate that it determines, in its sole discretion, represents the same
or a substantially similar measure or benchmark as the applicable EUR ICE swap rate, and the calculation agent may deem that rate (the
“successor rate”) to be the applicable EUR ICE swap rate. Upon the selection of any successor rate by the calculation agent
pursuant to this paragraph, references in this pricing supplement to the original EUR ICE swap rate will no longer be deemed to refer
to the original EUR ICE swap rate and will be deemed instead to refer to that successor rate for all purposes. In such event, the calculation
agent will make such adjustments, if any, to any value of the applicable EUR ICE swap rate that is used for purposes of the securities
and to any other terms of the securities as it determines are appropriate in the circumstances. Upon any selection by the calculation
agent of a successor rate, the calculation agent will cause notice to be furnished to us and the trustee.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the calculation and publication of a EUR ICE swap rate is permanently
canceled and no successor rate is chosen as described above, then the calculation agent will calculate the value of the applicable EUR
ICE swap rate on each subsequent date of determination in good faith and using its reasonable judgment. Such value, as calculated by the
calculation agent, will be the relevant EUR ICE swap rate for all purposes.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Notwithstanding these alternative arrangements, the cancellation of
a EUR ICE swap rate may adversely affect payments on, and the value of, the securities.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Calculation Agent</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The “<B>calculation agent</B>” for the securities is our
affiliate, Citibank, N.A., or any successor appointed by us. The calculation agent will make the determinations specified in this pricing
supplement. All determinations made by the calculation agent will be at the sole discretion of the calculation agent and will, in the
absence of manifest error, be conclusive for all purposes and binding on Citigroup Global Markets Holdings Inc., Citigroup Inc. and the
holders of the securities. The calculation agent is obligated to carry out its duties and functions in good faith and using its reasonable
judgment.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Events of Default and Acceleration</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In case an event of default (as described in the accompanying prospectus)
with respect to the securities shall have occurred and be continuing, the amount declared due and payable upon any acceleration of the
securities will be determined by the calculation agent and will equal, for each security, the payment at maturity, calculated as though
the date of such acceleration were the valuation date.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In case of default in making any payment under the securities, no interest
will accrue on such overdue payment either before or after the maturity date.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<!-- Field: Page; Sequence: 10; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F29400">Historical Information on the Synthetic 5Y5Y EUR CMS
Rate</P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F29400"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The graph below shows the daily synthetic 5Y5Y EUR CMS rate for each
day the underlying EUR CMS10 and EUR CMS5 rates were available from January 2, 2015 through February 10, 2025 using historical data for
EUR CMS10 and EUR CMS5 obtained from Bloomberg. The historical values of the synthetic 5Y5Y EUR CMS rate should not be taken as an indication
of the future values of the synthetic 5Y5Y EUR CMS rate during the term of the securities, including on the valuation date.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">On February 10, 2025, the synthetic 5Y5Y EUR CMS rate was 2.408%.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: #FBF0E8">
<TD STYLE="padding-top: 4pt; width: 100%; border: Black 1pt solid; text-align: center; font-size: 10pt; padding-bottom: 4pt"><FONT STYLE="color: #F19300"><B>Historical Synthetic 5Y5Y EUR CMS Rate</B><BR>
<B>January 2, 2015 to February 10, 2025</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; font-size: 10pt"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 433px; width: 673px"></TD></TR>
</TABLE>
<!-- Field: Page; Sequence: 11; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"><FONT STYLE="font-weight: normal">United States Federal
Tax Considerations</FONT></P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should note that the discussion under the section called “United
States Federal Tax Considerations” in the accompanying prospectus supplement generally does not apply to the securities issued under
this pricing supplement and is superseded by the following discussion. However, the discussion below is subject to the discussion in “United
States Federal Tax Considerations—Possible Taxable Event” in the accompanying prospectus supplement, and you should read it
in conjunction with that discussion.</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a discussion of the material U.S. federal income and
certain estate tax consequences of the ownership and disposition of the securities. It applies to you only if you purchase a security
for cash in the initial offering at the “issue price,” which is the first price at which a substantial amount of the securities
is sold to the public (not including sales to bond houses, brokers or similar persons or organizations acting in the capacity of underwriters,
placement agents or wholesalers), and hold it as a capital asset within the meaning of Section 1221 of the Internal Revenue Code of 1986,
as amended (the “Code”). Purchasers of securities at another time or price should consult their tax advisers regarding the
U.S. federal tax consequences to them of the ownership and disposition of the securities. This discussion does not address all of the
tax consequences that may be relevant to you in light of your particular circumstances or if you are a holder subject to special rules,
such as:</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>a financial institution;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>a “regulated investment company”;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>a tax-exempt entity, including an “individual retirement
account” or “Roth IRA”;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>a dealer or trader subject to a mark-to-market method of
tax accounting with respect to the securities;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>a person holding a security as part of a “straddle”
or conversion transaction or one who enters into a “constructive sale” with respect to a security;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>a person subject to special tax accounting rules under Section
451(b) of the Code;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>a U.S. Holder (as defined below) whose functional currency
is not the U.S. dollar; or</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>an entity classified as a partnership for U.S. federal income
tax purposes.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If an entity that is classified as a partnership for U.S. federal income
tax purposes holds the securities, the U.S. federal income tax treatment of a partner will generally depend on the status of the partner
and the activities of the partnership. If you are a partnership holding the securities or a partner in such a partnership, you should
consult your tax adviser as to the particular U.S. federal tax consequences of holding and disposing of the securities to you.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">This discussion is based on the Code, administrative pronouncements,
judicial decisions and final, temporary and proposed Treasury regulations, all as of the date of this pricing supplement, changes to any
of which subsequent to the date of this pricing supplement may affect the tax consequences described herein, possibly with retroactive
effect. This discussion does not address the effects of any applicable state, local or non-U.S. tax laws or the potential application
of the Medicare contribution tax or the alternative minimum tax. You should consult your tax adviser about the application of the U.S.
federal income and estate tax laws (including the possibility of alternative treatments of the securities) to your particular situation,
as well as any tax consequences arising under the laws of any state, local or non-U.S. jurisdiction.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Tax Treatment of the Securities</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of our counsel, Davis Polk & Wardwell LLP, a security
should be treated as a prepaid financial contract that is an “open transaction” for U.S. federal income tax purposes. By purchasing
a security, you agree (in the absence of an administrative determination or judicial ruling to the contrary) to this treatment. There
is uncertainty regarding this treatment, and the IRS or a court might not agree with it. Moreover, our counsel’s opinion is based
on market conditions as of the date of this preliminary pricing supplement and is subject to confirmation on the pricing date.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Alternative U.S. federal income tax treatments of the securities are
possible that, if applied, could materially and adversely affect the timing and character of income, gain or loss with respect to the
securities. For example, the IRS could treat the securities as debt instruments (a "short-term obligation") issued by us, in
which case some or all of the gain you realize on a sale, exchange or retirement of the short-term obligation would be treated as ordinary
income. Because the securities provide for a supplemental redemption amount that is not fixed as of the issue date, certain aspects of
the tax treatment of the securities as short-term obligations would be uncertain and U.S. Holders should consult their tax advisers regarding
the proper treatment in the event that the IRS seeks to treat the securities as debt instruments. A U.S. Holder could also be subject
to special reporting requirements if any loss on the securities exceeded certain thresholds.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If you are a Non-U.S. Holder, an alternative treatment of the securities
could result in adverse U.S. federal withholding tax consequences to you. Even if an exemption from withholding tax applies to the securities
under an alternative treatment, you might be required to provide different or additional IRS forms or certifications to establish your
eligibility for the exemption.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<!-- Field: Page; Sequence: 12; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Moreover, if there is a change to the securities that results in the
securities being treated as retired and reissued for U.S. federal income tax purposes, as discussed in “United States Federal Tax
Considerations—Possible Taxable Event” in the accompanying prospectus supplement, the treatment of the securities after such
an event could differ from their prior treatment.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The U.S. Treasury Department and the IRS have requested comments on
various issues regarding the U.S. federal income tax treatment of “prepaid forward contracts” and similar financial instruments
and have indicated that such transactions may be the subject of future regulations or other guidance. In addition, members of Congress
have proposed legislative changes to the tax treatment of derivative contracts. Any legislation, Treasury regulations or other guidance
promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the securities,
possibly with retroactive effect.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>We do not plan to request a ruling from the IRS, and the IRS or a
court might not agree with the treatment and consequences described below. Unless otherwise stated, the following discussion is based
on the treatment of the securities for U.S. federal income tax purposes as prepaid financial contracts that are “open transactions.”
You should consult your tax adviser regarding the risk that an alternative U.S. federal income tax treatment applies to the securities.</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Tax Consequences to U.S. Holders</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">This section applies only to U.S. Holders. You are a “U.S. Holder”
if for U.S. federal income tax purposes you are a beneficial owner of a security that is:</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>a citizen or individual resident of the United States;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>a corporation created or organized in or under the laws of
the United States, any state thereof or the District of Columbia; or</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>an estate or trust the income of which is subject to U.S.
federal income taxation regardless of its source.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Tax Treatment Prior to Maturity</I></B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should not be required to recognize income over the term of the
securities prior to maturity, other than pursuant to a sale, exchange or retirement as described below.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Taxable Disposition of the Securities</I></B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Upon a taxable disposition (including a sale, exchange or retirement)
of a security, you should recognize gain or loss equal to the difference between the amount realized and your tax basis in the security,
in each case as translated into U.S. dollars at the relevant spot rate. Your tax basis in a security should generally equal the amount
you paid to acquire it.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">There is significant uncertainty about whether the character of any
gain or loss you recognize upon a taxable disposition of the securities is treated as short-term capital gain or loss, ordinary foreign
currency gain or loss, or, in the case of gain or loss recognized at maturity, ordinary income or loss (other than foreign currency gain
or loss). This determination could have a significant effect on the tax consequences to you of owning a security. Among other things,
an ordinary loss (other than a foreign currency loss) recognized by an individual might be treated as a non-deductible “miscellaneous
itemized deduction.” The deductibility of capital losses is subject to limitations. As noted below, special reporting
requirements may apply to you if you recognize a foreign currency loss above a specified threshold. In light of the significant uncertainty
regarding this issue, you should consult your tax adviser regarding the character of this gain or loss.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If you are a U.S. Holder that acquires your securities with foreign
currency that you held before the date you acquire your securities, you generally will be treated as disposing of your foreign currency
for its U.S. dollar value at the time you acquire your securities and will recognize ordinary foreign currency gain or loss as a consequence.
Your basis in foreign currency received in connection with the taxable disposition of your securities generally will equal the U.S. dollar
value of the foreign currency at the time of receipt. If you do not dispose of the foreign currency at the time of receipt, a subsequent
disposition will give rise to ordinary foreign currency gain or loss as described above. You should consult your tax adviser about reporting
requirements that may apply to you if you recognize a foreign currency loss above a specified threshold.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Tax Consequences to Non-U.S. Holders</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">This section applies only to Non-U.S. Holders. You are a “Non-U.S.
Holder” if for U.S. federal income tax purposes you are a beneficial owner of a security that is:</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>an individual who is classified as a nonresident alien;</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>a foreign corporation; or</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">·</FONT></TD><TD>a foreign trust or estate.</TD>
</TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You are not a Non-U.S. Holder for purposes of this discussion if you
are (i) an individual who is present in the United States for 183 days or more in the taxable year of disposition or (ii) a former citizen
or resident of the United States and certain conditions apply. If you are or may become such a person during the period in which you hold
a security, you should consult your tax adviser regarding the U.S. federal tax consequences of an investment in the securities.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<!-- Field: Page; Sequence: 13; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If income on the securities is effectively connected with your conduct
of a trade or business in the United States, see “—Effectively Connected Income” below.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Taxable Disposition of the Securities</I></B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Subject to the discussion below regarding “FATCA,” you generally
should not be subject to U.S. federal withholding or income tax in respect of amounts paid to you upon a taxable disposition of a security.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>Effectively Connected Income</I></B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If you are engaged in a U.S. trade or business, and if income or gain
from the securities is effectively connected with the conduct of that trade or business, you generally will be subject to regular U.S.
federal income tax with respect to that income or gain in the same manner as if you were a U.S. Holder, subject to the provisions of an
applicable income tax treaty. If you are a corporation, you should also consider the potential application of a 30% (or lower treaty rate)
branch profits tax. You would be required to provide an IRS Form W-8ECI to the applicable withholding agent to establish an exemption
from withholding for amounts, otherwise subject to withholding, paid on the securities.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>U.S. Federal Estate Tax</I></B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If you are an individual Non-U.S. Holder or an entity the property of
which is potentially includible in such an individual’s gross estate for U.S. federal estate tax purposes (for example, a trust
funded by such an individual and with respect to which the individual has retained certain interests or powers), you should note that,
absent an applicable treaty exemption, a security may be treated as U.S.-situs property subject to U.S. federal estate tax. If you are
such an individual or entity, you should consult your tax adviser regarding the U.S. federal estate tax consequences of investing in the
securities.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Information Reporting and Backup Withholding</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment of the proceeds of a sale, exchange or other disposition (including
retirement) of the securities may be subject to information reporting and, if you fail to provide certain identifying information (such
as an accurate taxpayer identification number if you are a U.S. Holder) or meet certain other conditions, may also be subject to backup
withholding at the rate specified in the Code. If you are a Non-U.S. Holder that provides the applicable withholding agent with the appropriate
IRS Form W-8, you will generally establish an exemption from backup withholding. Amounts withheld under the backup withholding rules are
not additional taxes and may be refunded or credited against your U.S. federal income tax liability, provided the relevant information
is timely furnished to the IRS.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>FATCA </B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Legislation commonly referred to as “FATCA” generally imposes
a withholding tax of 30% on payments to certain non-U.S. entities (including financial intermediaries) with respect to certain financial
instruments, unless various U.S. information reporting and due diligence requirements (that are in addition to, and potentially significantly
more onerous than, the requirement to deliver an IRS Form W-8) have been satisfied. An intergovernmental agreement between the United
States and the non-U.S. entity’s jurisdiction may modify these requirements. This legislation generally applies to payments of U.S.-source
“fixed or determinable annual or periodical” (FDAP) income. While existing Treasury regulations would also require withholding
on payments of gross proceeds from the disposition of financial instruments that provide for U.S.-source interest or certain dividend
equivalents, the U.S. Treasury Department has indicated in subsequent proposed regulations its intent to eliminate this requirement. The
U.S. Treasury Department has stated that taxpayers may rely on these proposed regulations pending their finalization. If you are a Non-U.S.
Holder, or a U.S. Holder holding securities through a non-U.S. intermediary, you should consult your tax adviser regarding the potential
application of FATCA to the securities, including the availability of certain refunds or credits.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>WE WILL NOT BE REQUIRED TO PAY ANY ADDITIONAL AMOUNTS WITH RESPECT
TO U.S. FEDERAL WITHHOLDING TAXES.</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><B>THE TAX CONSEQUENCES OF OWNING AND DISPOSING OF
THE SECURITIES ARE UNCLEAR. YOU SHOULD CONSULT YOUR TAX ADVISER REGARDING THE TAX CONSEQUENCES OF OWNING AND DISPOSING OF THE SECURITIES,
INCLUDING THE TAX CONSEQUENCES UNDER STATE, LOCAL, NON-U.S. AND OTHER TAX LAWS AND THE POSSIBLE EFFECTS OF CHANGES IN U.S. FEDERAL OR
OTHER TAX LAWS.</B></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"> </P>
<!-- Field: Page; Sequence: 14; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"><FONT STYLE="font-weight: normal">Benefit Plan Investor
Considerations</FONT></P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A fiduciary of a pension, profit-sharing or other employee benefit plan
subject to the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), including entities such as collective
investment funds, partnerships and separate accounts whose underlying assets include the assets of such plans (collectively, “ERISA
Plans”), should consider the fiduciary standards of ERISA in the context of the ERISA Plan’s particular circumstances before
authorizing an investment in the securities. Among other factors, the fiduciary should consider whether the investment would satisfy the
prudence and diversification requirements of ERISA and would be consistent with the documents and instruments governing the ERISA Plan.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Section 406 of ERISA and Section 4975 of the Internal Revenue Code of
1986, as amended, (the “Code”) prohibit ERISA Plans, as well as plans (including individual retirement accounts and Keogh
plans) subject to Section 4975 of the Code (together with ERISA Plans, “Plans”), from engaging in certain transactions involving
the “plan assets” with persons who are “parties in interest” under ERISA or “disqualified persons”
under Section 4975 of the Code (in either case, “Parties in Interest”) with respect to such Plans. As a result of our business,
we, and our current and future affiliates, may be Parties in Interest with respect to many Plans. Where we (or our affiliate) are a Party
in Interest with respect to a Plan (either directly or by reason of our ownership interests in our directly or indirectly owned subsidiaries),
the purchase and holding of the securities by or on behalf of the Plan could be a prohibited transaction under Section 406 of ERISA and/or
Section 4975 of the Code, unless exemptive relief were available under an applicable exemption (as described below).</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Certain prohibited transaction class exemptions (“PTCEs”)
issued by the U.S. Department of Labor may provide exemptive relief for direct or indirect prohibited transactions resulting from the
purchase or holding of the securities. Those class exemptions are PTCE 96-23 (for certain transactions determined by in-house asset managers),
PTCE 95-60 (for certain transactions involving insurance company general accounts), PTCE 91-38 (for certain transactions involving bank
collective investment funds), PTCE 90-1 (for certain transactions involving insurance company separate accounts) and PTCE 84-14 (for certain
transactions determined by independent qualified asset managers). In addition, ERISA Section 408(b)(17) and Section 4975(d)(20) of the
Code may provide a limited exemption for the purchase and sale of the securities and related lending transactions, <I>provided</I> that
neither the issuer of the securities nor any of its affiliates have or exercise any discretionary authority or control or render any investment
advice with respect to the assets of the Plan involved in the transaction and <I>provided further</I> that the Plan pays no more, and
receives no less, than adequate consideration in connection with the transaction (the so-called “service provider exemption”).
There can be no assurance that any of these statutory or class exemptions will be available with respect to transactions involving the
securities.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Accordingly, the securities may not be purchased or held by any Plan,
any entity whose underlying assets include “plan assets” by reason of any Plan’s investment in the entity (a “Plan
Asset Entity”) or any person investing “plan assets” of any Plan, unless such purchaser or holder is eligible for the
exemptive relief available under PTCE 96-23, 95-60, 91-38, 90-1 or 84-14 or the service provider exemption or there is some other basis
on which the purchase and holding of the securities will not constitute a non-exempt prohibited transaction under ERISA or Section 4975
of the Code. Each purchaser or holder of the securities or any interest therein will be deemed to have represented by its purchase or
holding of the securities that (a) it is not a Plan and its purchase and holding of the securities is not made on behalf of or with “plan
assets” of any Plan or (b) its purchase and holding of the securities will not result in a non-exempt prohibited transaction under
Section 406 of ERISA or Section 4975 of the Code.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Certain governmental plans (as defined in Section 3(32) of ERISA), church
plans (as defined in Section 3(33) of ERISA) and non-U.S. plans (as described in Section 4(b)(4) of ERISA) (“Non-ERISA Arrangements”)
are not subject to these “prohibited transaction” rules of ERISA or Section 4975 of the Code, but may be subject to similar
rules under other applicable laws or regulations (“Similar Laws”). Accordingly, each such purchaser or holder of the securities
shall be required to represent (and deemed to have represented by its purchase of the securities) that such purchase and holding is not
prohibited under applicable Similar Laws.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the complexity of these rules, it is particularly important that
fiduciaries or other persons considering purchasing the securities on behalf of or with “plan assets” of any Plan consult
with their counsel regarding the relevant provisions of ERISA, the Code or any Similar Laws and the availability of exemptive relief under
PTCE 96-23, 95-60, 91-38, 90-1, 84-14, the service provider exemption or some other basis on which the acquisition and holding will not
constitute a non-exempt prohibited transaction under ERISA or Section 4975 of the Code or a violation of any applicable Similar Laws.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The securities are contractual financial instruments. The financial
exposure provided by the securities is not a substitute or proxy for, and is not intended as a substitute or proxy for, individualized
investment management or advice for the benefit of any purchaser or holder of the securities. The securities have not been designed and
will not be administered in a manner intended to reflect the individualized needs and objectives of any purchaser or holder of the securities.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Each purchaser or holder of any securities acknowledges and agrees that:</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD>the purchaser or holder or its fiduciary has made and shall make all investment decisions for the purchaser or holder and the purchaser
or holder has not relied and shall not rely in any way upon us or our affiliates to act as a fiduciary or adviser of the purchaser or
holder with respect to (A) the design and terms of the securities, (B) the purchaser or holder’s investment in the securities, or
(C) the exercise of or failure to exercise any rights we have under or with respect to the securities;</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<!-- Field: Page; Sequence: 15; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD>we and our affiliates have acted and will act solely for our own account in connection with (A) all transactions relating to the securities
and (B) all hedging transactions in connection with our obligations under the securities;</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(iii)</TD><TD>any and all assets and positions relating to hedging transactions by us or our affiliates are assets and positions of those entities
and are not assets and positions held for the benefit of the purchaser or holder;</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(iv)</TD><TD>our interests are adverse to the interests of the purchaser or holder; and</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(v)</TD><TD>neither we nor any of our affiliates is a fiduciary or adviser of the purchaser or holder in connection with any such assets, positions
or transactions, and any information that we or any of our affiliates may provide is not intended to be impartial investment advice.</TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Each purchaser and holder of the securities has exclusive responsibility
for ensuring that its purchase, holding and subsequent disposition of the securities does not violate the fiduciary or prohibited transaction
rules of ERISA, the Code or any applicable Similar Laws. The sale of any securities to any Plan is in no respect a representation by us
or any of our affiliates or representatives that such an investment meets all relevant legal requirements with respect to investments
by Plans or Non-ERISA Arrangements generally or any particular Plan or Non-ERISA Arrangement, or that such an investment is appropriate
for Plans or Non-ERISA Arrangements generally or any particular Plan or Non-ERISA Arrangement.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">However, individual retirement accounts,
individual retirement annuities and Keogh plans, as well as employee benefit plans that permit participants to direct the investment of
their accounts, will not be permitted to purchase or hold the securities if the account, plan or annuity is for the benefit of an employee
of CGMI or a family member and the employee receives any compensation (such as, for example, an addition to bonus) based on the purchase
of securities by the account, plan or annuity.</FONT></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"><FONT STYLE="font-weight: normal">Supplemental Plan
of Distribution</FONT></P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will not receive any underwriting fee for any securities sold in
this offering.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI is an affiliate of ours. Accordingly, this offering will conform
with the requirements addressing conflicts of interest when distributing the securities of an affiliate set forth in Rule 5121 of the
Financial Industry Regulatory Authority. Client accounts over which Citigroup Inc. or its subsidiaries have investment discretion will
not be permitted to purchase the securities, either directly or indirectly, without the prior written consent of the client.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See “Plan of Distribution” in each of the accompanying prospectus
supplement and prospectus for additional information.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">A portion of the net proceeds from the sale of the securities will be
used to hedge our obligations under the securities. We expect to hedge our obligations under the securities through CGMI or other of our
affiliates. CGMI or such other of our affiliates may profit from this expected hedging activity even if the value of the securities declines.
This hedging activity could affect the synthetic 5Y5Y EUR CMS rate and, therefore, the value of and your return on the securities. For
additional information on the ways in which our counterparties may hedge our obligations under the securities, see “Use of Proceeds
and Hedging” in the accompanying prospectus.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"><FONT STYLE="font-weight: normal">Valuation of the Securities</FONT></P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #F19300"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI’s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the “bond component”) and one or more derivative instruments underlying
the economic terms of the securities (the “derivative component”). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under “Risk Factors Relating to the Securities—The value of the securities prior to
maturity will fluctuate based on many unpredictable factors” in this pricing supplement, but not including our or Citigroup Inc.’s
creditworthiness. These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The estimated value of the securities
is a function of the terms of the securities and the inputs to CGMI’s proprietary pricing models. As of the date of this
preliminary pricing supplement, it is uncertain what the estimated value of the securities will be on the pricing date because it is uncertain
what the values of the inputs to CGMI’s proprietary pricing models will be on the pricing date.</FONT></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately 1.5 months following issuance of the securities,
the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated for the securities
on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one or more financial
information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined. This temporary
upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the term of the securities.
The amount of this temporary</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<!-- Field: Page; Sequence: 16; Value: 2 -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #F19300 1pt solid; font-size: 12pt; text-align: right"><FONT STYLE="font-size: 14pt; color: #888888">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 12pt"></TD></TR></TABLE></DIV>
<!-- Field: /Page -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">upward adjustment will decline to zero on a straight-line basis over
the 1.5-month temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time. See “Risk
Factors Relating to the Securities—The securities will not be listed on any securities exchange and you may not be able to sell
them prior to maturity.”</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">© 2025 Citigroup Global Markets Inc. All rights reserved. Citi
and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout the
world.</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"> </P>
<!-- Field: Page; Sequence: 17; Options: Last -->
<DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="color: rgb(241,147,0); border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 50%"> </TD><TD STYLE="text-align: right; width: 50%">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
<!-- Field: /Page -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P 1" &Q J$# 2( A$! Q$!_\0
M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4%
M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$!
M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#V:BBB@ JE
MJNJPZ/9?:;A7*;U3"X'+' Y) ]R:NU7O();FW,<-PUN^<[U56_#!!% %:\U
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %9GB"[N;/2)7LDE:9OD5XX]YCS_'M[X_GBM.B@#D;G79)='TP_;9+4O$
M#=3% KJ_E;E!!&!N/MST[T_0-5U"\U.);N9O.=9?M-J5 %OMV[".,C.>YYS[
M5U=% "'IQ3=S_P!P?]]4^B@!FY_[@_[ZHW/_ '!_WU3Z* &;G_N#_OJC<_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !14<TT=
MO"TLSA(U&2Q[4V"[@N7=895=DQN [9Z5+G%/EOJ/E=KVT)J***H04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P ]KV\:*4VM9)?@E_P3"&N1Q>&TMXI#]I"[#CC:.>?R_G6/ ;F1390@D3,
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MC@.,*1^1KH* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH JZFXCTNZ9NGE-
M_*N:#K90Z'<S ^6@;<0.>?\ ]=/N;U_^)Y#-(S(#A 3T.<8%2ZU9D>&+1F.U
MH%7*^N0!7AXBJZW-4@OA7Y2_X!Z=&G[.T9=7^<?^"6;H&?Q98X;Y5A+C]:WJ
MP4._Q1:;>=MIS^M;U>AA-?:/O+]$<F(TY%Y?JR&YM(;L()T#A&#K[$5-1176
MHI.Z1A=VL%%%%,04444 %%%% &7J&B+?ZA!=>;L,6,@+G=@YK4HHK.%*$)2E
M%:O<N524DDWL0P6D%L7,$21ESEMHQDU-115J*BK)$MMZL*IWNEVFH$-<1;F"
ME0V<$"KE%*<(S7+)70XR<7>+L<_8^&5M=4:1RLMNJ_('Y.[W^E5M)NCINJ7U
MD%!B7?(,]>!Q^E=37+>+$%O<07$0VO(K([#N,#^A->5BL/#"4U5I*W*[_)Z'
M=0JRKS=.IK=?D3Z+8"30[F<*#/=(XSGMS@?G6];@K;1 C!" $?A5;1[<VNDV
M\3,&(7.1[\_UJ[7;A**ITX][+_,YJ]1SG+U"BBBNHP"L'QA(RZ*$BCBDG>51
M$KR;&#=<I\RDL/8UO53U6VL;G3IAJ5K%<VT:EV22,., 9Z'O0!A>%K%-%GDC
MO)H#=W85E<S@NYY8ILZ9!)Y7@]>*ZFN*\"W?AW4II9-'T*WT^>.))&9(X\A7
M+;1N7O@9Q[UTVLW0L],DF:[%H%(_>;0QSG@ '@DG@?6@"_17-7^M745C81M=
MVUO=2(3<RKM=8W$9?;UQR?T!QZTS0=>O=1U"#[0T8$XEWVH7#6^S;@D]><]_
M48H ZBBD/3UIN]O^>;?I_C0 ^BF;V_YYM^G^-(\K*C-Y;<#/44 245C6OB&-
MM.BN;I-ADD,8"<\UK;V_YYM^G^-94JT*JO!_TRYTY0=I(?13-[?\\V_3_&C>
MW_/-OT_QK4@?13-[?\\V_3_&C>W_ #S;]/\ &@!]%,WM_P \V_3_ !HWM_SS
M;]/\: 'T4S>W_/-OT_QHWM_SS;]/\: 'T4S>W_/-OT_QHWM_SS;]/\: 'T4S
M>W_/-OT_QHWM_P \V_3_ !H ?13-[?\ /-OT_P :-[?\\V_3_&@!]%,WM_SS
M;]/\:-[?\\V_3_&@!]%,WM_SS;]/\:-[?\\V_3_&@!]%,WM_SS;]/\:-[?\
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M%%%=ASA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=7;2O&IF^48R<=?\*9I]M/9>)K:VN&+&/.WG(V[3TK=\/V$^G6#Q7 <R%A@
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MZL#D]>_]*NZ%K4EM=A;NX;[,$(PW(7'3%;MKH$<&HSW3R;_,)VKM^Z#UK/\
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M_;?\Z 'T4SR_]M_SH\O_ &W_ #H ?13/+_VW_.CR_P#;?\Z 'T4SR_\ ;?\
M.CR_]M_SH ?13/+_ -M_SH\O_;?\Z ,7Q+JIM(/LL8(EF7[P/W1GFK7AT%=#
MMLC'!/ZFLZ]L(K_Q2L$Y<IY&XX.#WK?CMUBC6.-F5%& >@KSL/&I/$SJR>B
M]U'95<(T8TUN]62T4SR_]M_SH\O_ &W_ #KT3C'T4SR_]M_SH\O_ &W_ #H
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ME6'>J>L:D-,L3+MW.QVH/>LYU8P@ZDGHBHPE*7*MRG"/-\7W#'_EE /QQ_C
M6W7-^&'EO+N\O)\F1@J[L8'T_05TE<V!ESTG47VFW^)MBERSY>R2_ ****[3
MG"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHH 2EHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YSQ=:*;:*[&
MZ-L/'4'_ _K5SPQ.DNC1HN=T1*M]<Y_K4VMV$NHV'D0E0V\-\WI5#PVK6=U
M>V$@^:-@X/J.G^%>2X.EC^=+22M?S_I'?S*>%Y;ZIW^7],Z"F&:,2B(NHD89
M"YY(^E.9@JEF( R2>U<C<:S$GB1KP$R111E$VG[W'^)KLQ6*CAU%RZO\.K.
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<J5%RB[-NQ=50JA5 ' J"^@-U83PCJZ$#/KVJQ17=**E%Q>S.5-IW.=\,W
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M 'R:?10 SS5]_P#ODT>:OO\ ]\FGT4 ,\U??_ODT>:OO_P!\FGT4 ,\U??\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !39(UEC9)%#(PP0>XI
MU%#5P&11)#$L<2A448"CL*?110E;1!>X4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 444C,$4LQ ZDF@!:*:\B1 &1U4$XRQQS1YB&0Q[UW@9*YYQZXH
M=1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %8GB:PN[_ $>]@BBCNA+%
MMB@VA2K]F+,V,#Z5MT4 <WKUE?:IY6W3A+&D+KY<DJ??=, ^GRD=?]KC-,T_
M1+RWUR*6:)6\J1I'N]PS*IC"!,=>",\\<#O73T4 -?=M.WKVI-C?\]#^0K-U
MF*]E>%+:\CMH'!29B^UP,J<H<'G 8?C4VC;Q8%)+H7.R1U63=N.T,< GN0,
MT 7-C?\ /0_D*1E<*=LA)[<"I*SM:FOH+17TY8FDW$$2,%&"IP<GT.#0!>V-
M_P ]#^0HV-_ST/Y"L_1GN/\ 2H;B\6\\J0!)?EW$%03N"\#DG'M6G0 S8W_/
M0_D*15<CYG(/T%5]5>2+39GAGB@=0&$DS;4&",Y/8=JR=!N2^I/&=7BOG>'S
M98TE$@1]W\.!\JX./?\ .@#?V-_ST/Y"C8W_ #T/Y"GTR52T3JK[&*D!O[I]
M: $"R<Y<]>.!2[&_YZ'\A7-:6FIQZW&U]?P,K$J%6Z+B4!. (]H"G(+$Y]17
M44 ,V-_ST/Y"D"R;CESCMP*DKCI+RY37HU?6;0QK.L:;;SYN7.4:$+\S$$+U
MXQF@#KMC?\]#^0HV-_ST/Y"GT4 1E7W#]X<=^!2[&_YZ'\A7/:A=?8=1O)V\
M06]JXVLMM.ZN@0*.J<,"3DY!_.NAB<2PHX((90<CH: #8W_/0_D*0J_&)#UY
MX%25@ZK)Y&J-(VNQ6!\I?+BD=2K<G)9#U[<@@\4 ;>QO^>A_(4;&_P">A_(5
M%87(N[""<21R"1 V^,$*WN,\XJQ0!&RR ?+(2?H*78W_ #T/Y"LG7<K<6;OJ
MPTZ)=^6,BKO; V\,,,!SQ5G1KW[=9,WVRWO#'(T9F@4JI(]LGGUP<4 7=C?\
M]#^0I"KX.)#GMP*DK,UY[Y-/#::ZI,)!DDJ/EYZ%N.N/PSCF@"^$? S(<_04
MNQO^>A_(5D>')[Z6.Y349DDE1EZ,AP2H)QMZ+G.W/..M;5 #-C?\]#^0I%60
MJ-SD'Z"J^K%QI5SY5PEL_EG$SMM">Y/;Z]JPO#5Q.VK2Q3ZK#>?N2^V.Y\W
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M %I5?:,R'..>!2[&_P">A_(5FZ3]H-S,TVJ1WT;QQM&$0+M&6YXX(/K[5JT
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MG%;QO(P,PMT*IN X! [8K5K$\,"Y%K<"X^TE1+^[>X\P,R[1V<DCG(K;H C
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MD42$"5&&Y7&WJ!C%;=<CHTLM_P"(EO;;49+BS?>2OE,J#K@#Y >G4]CUS77
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MH **** (;BTM[L*+FWBF"_=\Q V/SI+2SM["$PVL2Q1;BVQ>@).3@=N34]%
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M=!6]10 4444 4GT;3WECE^Q0++'()%=$"L&]<CFKM%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5EZ_H<>OV$=L]S-;-%
M/'<1RP[=RNARIY!'7VK4HH XZ^^&UC?V7V>74M2W2.\EQ+YBEKAF !+ KCC:
M , 8 J;4/A_9:@]RS7MY&9KH7:;"A$4FS8Q *G(8=0<^V*ZNB@"MIUE'ING6
M]G#_ *N"-8U^4+D 8Z #\!5FBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
"_]D!
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>